Tectonic Therapeutic, Inc. (TECX)Healthcare | Biotechnology | Watertown, United States | NasdaqGM
35.62 USD
-1.08
(-2.943%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 35.62 |
Hot Take ↕ | Aug. 22, 2026, 2:56 a.m. EDT
The investment case for Tectonic Therapeutic is a classic tale of speculative optimism clashing with deteriorating fundamentals. While the options market is screaming 'moonshot' with massive open interest in far-out-of-the-money calls, the underlying business shows no signs of financial stability. The company is burning cash aggressively, with operating and free cash flows deeply negative, and has posted losses for five of the last seven years. Despite a recent price recovery that ended the multi-year decline, the stock remains down nearly 95% from its peak, and the balance sheet is fragile with significant debt relative to equity. The 'strong buy' analyst consensus appears to be pricing in a binary event—likely a successful Phase 2 trial—but ignores the reality that the company currently lacks the cash reserves to survive a prolonged period of failure without dilution. For now, the stock is a high-risk leveraged bet on a clinical milestone, not a sound investment in a viable business. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.089195 |
| AutoARIMA | 0.091368 |
| AutoETS | 0.096034 |
| AutoTheta | 0.097986 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 2.25 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.179 |
| Excess Kurtosis | -0.38 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.965 |
| Market Cap | 696,348,416 |
| Forward P/E | -7.61 |
| Beta | 0.22 |
| Website | https://tectonictx.com |
As of Aug. 22, 2026, 2:56 a.m. EDT: Speculators are overwhelmingly bullish, with open interest heavily concentrated in out-of-the-money calls (OTM OI % near 100% across expirations). The largest call positions sit at strikes significantly above the current price ($45 and $55), while put activity is negligible and confined to deep out-of-the-money strikes. This structure indicates a speculative bet on a sharp upward move rather than hedging against downside risk.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.2042043 |
| Address1 | 490 Arsenal Way |
| Address2 | Suite 210 |
| All Time High | 644.4 |
| All Time Low | 1.4 |
| Ask | 37.17 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Analyst Rating | 1.1 - Strong Buy |
| Average Daily Volume10 Day | 205,690 |
| Average Daily Volume3 Month | 186,340 |
| Average Volume | 186,340 |
| Average Volume10Days | 205,690 |
| Beta | 0.216 |
| Bid | 29.58 |
| Bid Size | 1 |
| Board Risk | 7 |
| Book Value | 12.236 |
| City | Watertown |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 35.62 |
| Current Ratio | 22.287 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 36.76 |
| Day Low | 34.95 |
| Debt To Equity | 1.965 |
| Display Name | Tectonic Therapeutic |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | -93,661,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -5.057 |
| Enterprise Value | 473,679,424 |
| Eps Forward | -4.68 |
| Eps Trailing Twelve Months | -4.43 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 32.8934 |
| Fifty Day Average Change | 2.7266006 |
| Fifty Day Average Change Percent | 0.08289203 |
| Fifty Two Week Change Percent | 120.42043 |
| Fifty Two Week High | 39.53 |
| Fifty Two Week High Change | -3.9099998 |
| Fifty Two Week High Change Percent | -0.09891222 |
| Fifty Two Week Low | 14.39 |
| Fifty Two Week Low Change | 21.23 |
| Fifty Two Week Low Change Percent | 1.47533 |
| Fifty Two Week Range | 14.39 - 39.53 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,529,587,800,000 |
| Float Shares | 11,911,820 |
| Forward Eps | -4.68 |
| Forward P E | -7.611111 |
| Free Cashflow | -46,723,124 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 60 |
| Fullday Change | -1.08 |
| Fullday Change Percent | -2.94278 |
| Fullday Price | 35.62 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.37846002 |
| Held Percent Institutions | 0.71686 |
| Implied Shares Outstanding | 19,549,366 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,718,928,000 |
| Last Split Factor | 1:12 |
| Long Business Summary | Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts. |
| Long Name | Tectonic Therapeutic, Inc. |
| Market | us_market |
| Market Cap | 696,348,416 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_711440557 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -85,787,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 717,657,225 |
| Number Of Analyst Opinions | 9 |
| Open | 36.11 |
| Operating Cashflow | -72,140,000 |
| Operating Margins | 0.0 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 339 666 3320 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 35.62 |
| Post Market Time | 1,787,959,806 |
| Previous Close | 36.7 |
| Price Hint | 2 |
| Price To Book | 2.911082 |
| Profit Margins | 0.0 |
| Quick Ratio | 21.899 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.1 |
| Region | US |
| Regular Market Change | -1.08 |
| Regular Market Change Percent | -2.94278 |
| Regular Market Day High | 36.76 |
| Regular Market Day Low | 34.95 |
| Regular Market Day Range | 34.95 - 36.76 |
| Regular Market Open | 36.11 |
| Regular Market Previous Close | 36.7 |
| Regular Market Price | 35.62 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 157,790 |
| Return On Assets | -0.22288999 |
| Return On Equity | -0.338 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 19,549,366 |
| Shares Percent Shares Out | 0.0883 |
| Shares Short | 1,726,909 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 1,936,691 |
| Short Name | Tectonic Therapeutic, Inc. |
| Short Percent Of Float | 0.17860001 |
| Short Ratio | 9.08 |
| Source Interval | 15 |
| State | MA |
| Symbol | TECX |
| Target High Price | 93.0 |
| Target Low Price | 60.0 |
| Target Mean Price | 77.55556 |
| Target Median Price | 80.0 |
| Total Cash | 227,068,000 |
| Total Cash Per Share | 11.615 |
| Total Debt | 4,399,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.43 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 26.9748 |
| Two Hundred Day Average Change | 8.645199 |
| Two Hundred Day Average Change Percent | 0.32049167 |
| Type Disp | Equity |
| Volume | 157,790 |
| Website | https://tectonictx.com |
| Zip | 2,472 |